Bezos’ Blue Origin wins NASA astronaut moon lander contract to compete with SpaceX’s Starship

Bezos’ Blue Origin wins NASA astronaut moon lander contract to compete with SpaceX’s Starship


The moon seen from the International Space Station on July 9, 2018. 

Alexander Gerst | NASA

WASHINGTON – Jeff Bezos has his NASA moon ticket.

The billionaire’s space company Blue Origin won a key contract from the National Aeronautics and Space Administration on Friday to develop a crewed lunar lander for delivering astronauts to the moon’s surface later this decade under the agency’s Artemis program.

The Blue Origin-led team – which includes Lockheed Martin, Boeing, Draper, Astrobotic and Honeybee Robotics – topped the proposal of a team led by Leidos-owned Dynetics. Other proposals were expected, but likely won’t be revealed until NASA releases documents explaining its selection process.

Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

Known as the Sustaining Lunar Development (SLD) program, the competition was effectively a second-chance contest that NASA organized after Elon Musk’s SpaceX was the sole winner of the first crew lander contract in 2021. 

That first program, called the Human Landing System (HLS), gave SpaceX a near $3 billion contract to develop a variation of its Starship rocket for Artemis missions. Prior to the HLS award, NASA was expected to choose two winners, but the agency’s budget at the time and SpaceX’s more-affordable bid resulted in there being a single winner.

Both HLS and SLD are part of NASA’s Artemis program to land astronauts on the moon, with the agency hoping to start flying crews to the lunar surface within the next few years. In December, NASA completed the first Artemis mission, which had no people on board, flying its Space Launch System (SLS) rocket and Orion spacecraft around the moon for the first time.

A messy saga

Jeff Bezos, left, and Elon Musk

Getty Images; Reuters

Competition with Starship

Why Starship is indispensable for the future of SpaceX

Last year, NASA Administrator Bill Nelson explained the reasoning behind a second bidding process to add another privately-built lunar lander, saying, “competition is critical to our success.” 

“We can leverage that money by working with a commercial industry and, through competition, bring those costs down to NASA,” Nelson said during Senate testimony in 2022.

SpaceX has continued to develop its nearly 400-foot-tall Starship rocket in the meantime. The company in April attempted to reach space with the vehicle for the first time. Recently, Musk estimated that SpaceX will spend about $2 billion on Starship development this year, and expects the company to reach orbit around the Earth with its next launch.

Last year, NASA gave SpaceX with an additional $1.15 billion award under the HLS contract, exercising an option to buy a second crewed demonstration landing from the company. That brought the total value of SpaceX’s HLS contract up to $4.2 billion through 2027.

To date, NASA has paid out about $1.8 billion to SpaceX under HLS, according to federal records.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More